Biden to send US-authorised Covid-19 vaccines abroad for first time


  • English
  • Arabic

US President Joe Biden plans to send an additional 20 million doses of coronavirus vaccines abroad by the end of June – including, for the first time, shots authorised for domestic use.

Mr Biden announced in White House remarks on Monday the export of 20 million doses of Pfizer-BioNTech, Moderna or Johnson & Johnson vaccines.

This is on top of 60 million AstraZeneca doses he had already planned to donate to other countries, according to a senior administration official familiar with the plan.

The official said the measures are only a first step in the US shift towards quelling the pandemic abroad.

“We know America will never be fully safe until the pandemic that’s raging globally is under control,” Mr Biden said.

Mr Biden previously pledged that the US would become an “arsenal” of global vaccine supply, but said he would only share US-purchased doses once there was enough supply to meet local demand – which is now the case.

"We will not use our vaccines to secure favours from other countries," Mr Biden added, in subtle reference to how China and Russia have deployed their domestically produced vaccines.

White House Press Secretary Jen Psaki confirmed the plan during the White House press briefing before Mr Biden's remarks.

"This is the most doses donated by any country in the world by five times," she said.

Jeff Zients, who has served as the White House coronavirus response co-ordinator, will be put in charge of the effort to beat the pandemic globally, the official said. Mr Zients will work with the National Security Council and other agencies to send doses abroad.

The announcement is a watershed moment in the pandemic and for Mr Biden’s administration.

The US government claimed almost all of the first few hundred million doses of vaccines produced on American soil.

This approach allowed Mr Biden to advance what has become one of the most successful domestic vaccination efforts in the world, but it has fuelled an imbalance between nations that produce their own shots and those that can’t.

The Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines are authorised for use in the US, but the AstraZeneca shot is not.

Mexico and Canada have received doses of the US AstraZeneca stockpile and Pfizer has begun shipping doses of its US-produced vaccine to Mexico, Canada and Uruguay, among other countries.

The US domestic vaccination campaign is beginning to run out of willing arms. Almost 60 per cent of adults have received at least one shot.

Meanwhile, scores of low-income nations and even some developed countries are struggling to secure vaccines.

Covax, a global programme aimed at easing vaccine procurement and access for lower-income countries, is short of supplies and expects the shortfall to reach about 190 million doses next month, the UN children's fund said on Monday.

Mr Biden previously pledged up to $4 billion for Covax.

  • A worker disinfects an area before it is set up as a vaccination centre to administer the Pfizer-BioNTech vaccine, in the Santa Maria de Ojial community, in Iquitos, Peru. Reuters
    A worker disinfects an area before it is set up as a vaccination centre to administer the Pfizer-BioNTech vaccine, in the Santa Maria de Ojial community, in Iquitos, Peru. Reuters
  • A doctor takes off her personal protection equipment (PPE) after treating a patient suffering from Covid-19 in the Intensive Care Unit at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand. Reuters
    A doctor takes off her personal protection equipment (PPE) after treating a patient suffering from Covid-19 in the Intensive Care Unit at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand. Reuters
  • A health worker inoculates a man with a dose of the Sinopharm vaccine at a vaccination centre in Rawalpindi, Pakistan. AFP
    A health worker inoculates a man with a dose of the Sinopharm vaccine at a vaccination centre in Rawalpindi, Pakistan. AFP
  • People take part in a gym class which began at one minute past midnight amid an easing of coronavirus restrictions, at the Park Road Fusion Lifestyle Gym in London. Legal restrictions on meeting others outdoors across the UK were lifted on 17 May. Indoor locations such as pubs, adult group sports and exercise classes and cinemas were allowed to reopen. EPA
    People take part in a gym class which began at one minute past midnight amid an easing of coronavirus restrictions, at the Park Road Fusion Lifestyle Gym in London. Legal restrictions on meeting others outdoors across the UK were lifted on 17 May. Indoor locations such as pubs, adult group sports and exercise classes and cinemas were allowed to reopen. EPA
  • People wearing face masks walk by a worker using her smartphone outside a restaurant in Beijing. AP Photo
    People wearing face masks walk by a worker using her smartphone outside a restaurant in Beijing. AP Photo
  • A worker wearing personal protective equipment sorts funeral pyre wood at a crematorium in New Delhi, India. Bloomberg
    A worker wearing personal protective equipment sorts funeral pyre wood at a crematorium in New Delhi, India. Bloomberg
  • A Bahraini man holding Saudi and Bahraini national flags welcomes Saudis as they enter Bahrain via the King Fahad Causeway, after Saudi authorities lifted the travel ban on its citizens after 14 months due to coronavirus restrictions. Reuters
    A Bahraini man holding Saudi and Bahraini national flags welcomes Saudis as they enter Bahrain via the King Fahad Causeway, after Saudi authorities lifted the travel ban on its citizens after 14 months due to coronavirus restrictions. Reuters
  • A photo taken with a drone shows empty streets in the last weekend of mass confinement in Quito, Ecuador. A state of emergency was enforced on 23 April on 16 of the 24 provinces of Ecuador, amid the ongoing pandemic. EPA
    A photo taken with a drone shows empty streets in the last weekend of mass confinement in Quito, Ecuador. A state of emergency was enforced on 23 April on 16 of the 24 provinces of Ecuador, amid the ongoing pandemic. EPA

Manufacturing errors at a plant in Baltimore resulted in a batch of Johnson & Johnson’s shot becoming contaminated, greatly slowing production of the vaccine. It was once envisioned as a pillar of US supply, but the US has instead relied almost entirely on Pfizer-BioNTech and Moderna shots.

Mr Biden has faced pressure to do more to help the world during the pandemic, as the US winds down nearly all mitigation measures such as masking.

Other countries are trying to quell outbreaks and new variants with few or no vaccine doses.

The “new phase” of his pandemic effort is focused on efforts to persuade vaccine-hesitant adults to be immunised.

US caseloads continue to fall, with 16,857 new cases recorded on Sunday. This is the lowest daily total since March 2020, although this is typical for a Sunday.

The pace of vaccination has fallen by over a third from a month ago and is hovering now at about two million doses a day.

Vaccine exports have been a thorny issue for Mr Biden, who has tried to reclaim the mantle of US leadership abroad while adopting some of the “America First” approaches of his predecessor, Donald Trump, in his pandemic response.

While the EU and India balanced vaccine exports with domestic allocation, the US has for months cornered the market on its supply, effectively preventing early exports.

Both Mr Trump and Mr Biden used wartime powers to reserve plant resources and vaccine ingredients for domestic production, effectively placing the government at the front of the queue. American orders also include contractual clauses limiting the government’s ability to share doses abroad.

The administration sought to skirt those restrictions by framing the 4.2 million AstraZeneca doses already shipped to Mexico and Canada as a “loan”.

Our legal columnist

Name: Yousef Al Bahar

Advocate at Al Bahar & Associate Advocates and Legal Consultants, established in 1994

Education: Mr Al Bahar was born in 1979 and graduated in 2008 from the Judicial Institute. He took after his father, who was one of the first Emirati lawyers

Company%C2%A0profile
%3Cp%3E%3Cstrong%3ECompany%20name%3A%20%3C%2Fstrong%3Eamana%3Cbr%3E%3Cstrong%3EStarted%3A%20%3C%2Fstrong%3E2010%3Cbr%3E%3Cstrong%3EFounders%3A%3C%2Fstrong%3E%20Karim%20Farra%20and%20Ziad%20Aboujeb%3Cbr%3E%3Cstrong%3EBased%3A%20%3C%2Fstrong%3EUAE%3Cbr%3E%3Cstrong%3ERegulator%3A%20%3C%2Fstrong%3EDFSA%3Cbr%3E%3Cstrong%3ESector%3A%20%3C%2Fstrong%3EFinancial%20services%3Cbr%3E%3Cstrong%3ECurrent%20number%20of%20staff%3A%20%3C%2Fstrong%3E85%3Cbr%3E%3Cstrong%3EInvestment%20stage%3A%20%3C%2Fstrong%3ESelf-funded%3Cbr%3E%3C%2Fp%3E%0A
Sinopharm vaccine explained

The Sinopharm vaccine was created using techniques that have been around for decades. 

“This is an inactivated vaccine. Simply what it means is that the virus is taken, cultured and inactivated," said Dr Nawal Al Kaabi, chair of the UAE's National Covid-19 Clinical Management Committee.

"What is left is a skeleton of the virus so it looks like a virus, but it is not live."

This is then injected into the body.

"The body will recognise it and form antibodies but because it is inactive, we will need more than one dose. The body will not develop immunity with one dose," she said.

"You have to be exposed more than one time to what we call the antigen."

The vaccine should offer protection for at least months, but no one knows how long beyond that.

Dr Al Kaabi said early vaccine volunteers in China were given shots last spring and still have antibodies today.

“Since it is inactivated, it will not last forever," she said.

Results

6.30pm: Maiden Dh165,000 (Dirt) 1,600m

Winner: Celtic Prince, David Liska (jockey), Rashed Bouresly (trainer).

7.05pm: Conditions Dh240,000 (D) 1,600m

Winner: Commanding, Richard Mullen, Satish Seemar.

7.40pm: Handicap Dh190,000 (D) 2,000m

Winner: Grand Argentier, Pat Dobbs, Doug Watson.

8.15pm: Handicap Dh170,000 (D) 2,200m

Winner: Arch Gold, Sam Hitchcott, Doug Watson.

8.50pm: The Entisar Listed Dh265,000 (D) 2,000m

Winner: Military Law, Antonio Fresu, Musabah Al Muhairi.

9.25pm: The Garhoud Sprint Listed Dh265,000 (D) 1,200m

Winner: Ibn Malik, Dane O’Neill, Musabah Al Muhairi.

10pm: Handicap Dh185,000 (D) 1,400m

Winner: Midnight Sands, Pat Dobbs, Doug Watson.

Key figures in the life of the fort

Sheikh Dhiyab bin Isa (ruled 1761-1793) Built Qasr Al Hosn as a watchtower to guard over the only freshwater well on Abu Dhabi island.

Sheikh Shakhbut bin Dhiyab (ruled 1793-1816) Expanded the tower into a small fort and transferred his ruling place of residence from Liwa Oasis to the fort on the island.

Sheikh Tahnoon bin Shakhbut (ruled 1818-1833) Expanded Qasr Al Hosn further as Abu Dhabi grew from a small village of palm huts to a town of more than 5,000 inhabitants.

Sheikh Khalifa bin Shakhbut (ruled 1833-1845) Repaired and fortified the fort.

Sheikh Saeed bin Tahnoon (ruled 1845-1855) Turned Qasr Al Hosn into a strong two-storied structure.

Sheikh Zayed bin Khalifa (ruled 1855-1909) Expanded Qasr Al Hosn further to reflect the emirate's increasing prominence.

Sheikh Shakhbut bin Sultan (ruled 1928-1966) Renovated and enlarged Qasr Al Hosn, adding a decorative arch and two new villas.

Sheikh Zayed bin Sultan (ruled 1966-2004) Moved the royal residence to Al Manhal palace and kept his diwan at Qasr Al Hosn.

Sources: Jayanti Maitra, www.adach.ae

GAC GS8 Specs

Engine: 2.0-litre 4cyl turbo

Power: 248hp at 5,200rpm

Torque: 400Nm at 1,750-4,000rpm

Transmission: 8-speed auto

Fuel consumption: 9.1L/100km

On sale: Now

Price: From Dh149,900

CABINET%20OF%20CURIOSITIES%20EPISODE%201%3A%20LOT%2036
%3Cp%3E%3Cstrong%3EDirector%3A%20%3C%2Fstrong%3EGuillermo%20del%20Toro%3Cbr%3E%3Cstrong%3EStars%3A%3C%2Fstrong%3E%20Tim%20Blake%20Nelson%2C%20Sebastian%20Roche%2C%20Elpidia%20Carrillo%3Cbr%3ERating%3A%204%2F5%3C%2Fp%3E%0A